Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7085
Reference
Drug alert 44/2020
Name
Drug alert class 4 no 44 2020: caution in use: Ratiopharm UK Limited & Generic [UK] Limited t/a Mylan [Zopiclone 3.75mg and 7.5mg tablets]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Ratiopharm UK Limited and Generics [UK] Limited t/a Mylan have confirmed that the Patient Information Leaflet (PIL) within all packs and the Summary of Product Characteristics (SmPC) for Ratiopharm is missing important safety information related to potential suicide risks.
Contact Name
Elliot Paton
Contact Email
Contact Address
Scottish Government, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2020-09-10 00:00:00
Click to go back to homepage